首頁 > 市場調查報告書 > 醫療設備

心血管設備

市場調查報告書

商品編碼

1498689

全球心臟瓣膜刀市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Cardiac Valvulotome Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年06月01日 | 出版商:

Value Market Research | 英文 177 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球心臟瓣膜刀市場需求預計將從 2023 年的 1.3417 億美元達到 2032 年的近 2.0831 億美元，2024-2032 年研究期間複合年成長率為 5.01%。

心臟瓣膜切開器是一種用於心臟手術中進行瓣膜切開術的手術器械，其中涉及手術切口或打開心臟瓣膜。該裝置旨在透過擴大或修復受影響的瓣膜來促進各種心臟瓣膜疾病的治療，包括狹窄（變窄）或逆流（洩漏）。在手術過程中，瓣膜刀透過一個小切口小心地插入心室，使外科醫生能夠進入受影響的瓣膜並執行必要的糾正措施。心臟瓣膜切開術通常用於緩解與心臟瓣膜疾病相關的症狀並改善整體心臟功能，從而提高患者的生活品質。

市場動態

推動心臟瓣膜刀市場的因素主要圍繞在全球心血管疾病盛行率的不斷上升，特別是在老年人口中。隨著心臟病變得越來越普遍，對解決這些問題的先進醫療設備和程序的需求不斷增加。此外，心臟手術技術和設備的技術進步對市場成長做出了重大貢獻，提高了涉及心臟瓣膜刀的手術的有效性和安全性。此外，患者和醫療保健提供者對微創手術選擇的認知不斷提高，進一步推動了對心臟瓣膜刀的需求，因為它提供了比傳統心臟直視手術侵入性更小的方法。此外，醫療器材公司和醫療機構之間的合作和夥伴關係推動了市場創新，從而開發出更有效率、更精確的設備。然而，日益嚴格的醫療器材監管審查和嚴格的核准流程可能會對未來幾年的市場成長構成挑戰。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球心臟瓣膜刀市場的各個細分市場進行了包容性評估。心臟瓣膜刀產業的成長和趨勢為本研究提供了整體方法。

市場區隔

心臟瓣膜刀市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按類型

可擴張心臟瓣膜刀
有線心臟瓣膜切開器

按程式類型

瓣膜切開術
二尖瓣連合切開術
其他（三尖瓣狹窄等）

按最終用戶

醫院和診所
心臟手術中心
門診手術中心
其他（研究所等）

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲心臟瓣膜刀市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。心臟瓣膜刀市場的主要參與者包括LeMaitre、Invamed、LimFlow Inc.、B. Braun、Teleflex Incorporated、StarFish Medical、Koven Technology Inc.、BD、Symmetry Surgical Inc.、Andramed GmbH、OxSyBio。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：心臟瓣膜刀公司的競爭格局

心臟瓣膜刀市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
LeMaitre

公司簡介
公司收入
產品
最近的發展

Invamed

公司簡介
公司收入
產品
最近的發展

LimFlow Inc.

公司簡介
公司收入
產品
最近的發展

B. Braun

公司簡介
公司收入
產品
最近的發展

Teleflex Incorporated

公司簡介
公司收入
產品
最近的發展

StarFish Medical

公司簡介
公司收入
產品
最近的發展

Koven Technology Inc.

公司簡介
公司收入
產品
最近的發展

公司簡介
公司收入
產品
最近的發展

Symmetry Surgical Inc.

公司簡介
公司收入
產品
最近的發展

Andramed GmbH

公司簡介
公司收入
產品
最近的發展

OxSyBio

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112114869

The global demand for Cardiac Valvulotome Market is presumed to reach the market size of nearly USD 208.31 Million by 2032 from USD 134.17 Million in 2023 with a CAGR of 5.01% under the study period 2024-2032.

A cardiac valvulotome is a surgical instrument utilized in cardiac procedures to perform valvulotomy, which involves the surgical incision or opening of a heart valve. This device is designed to facilitate the treatment of various heart valve conditions, including stenosis (narrowing) or regurgitation (leakage), by widening or repairing the affected valve. During the procedure, the valvulotome is carefully inserted into the heart's chambers through a small incision, allowing surgeons to access the affected valve and perform the necessary corrective measures. Cardiac valvulotomy procedures are often performed to alleviate symptoms associated with heart valve disorders and improve overall cardiac function, thereby enhancing the patient's quality of life.

MARKET DYNAMICS

Factors driving the cardiac valvulotome market primarily revolve around the increasing prevalence of cardiovascular diseases globally, particularly among the aging population. As cardiac conditions become more prevalent, there's a rising demand for advanced medical devices and procedures to address them. Additionally, technological advancements in cardiac surgery techniques and equipment contribute significantly to the market growth, enhancing the efficacy and safety of procedures involving cardiac valvulotome. Moreover, rising awareness among patients and healthcare providers about minimally invasive surgical options further propels the demand for cardiac valvulotome, as it offers a less invasive approach than traditional open-heart surgeries. Furthermore, collaborations and partnerships between medical device companies and healthcare institutions drive innovation in the market, leading to the development of more efficient and precise devices. However, increasing regulatory scrutiny and stringent approval processes for medical devices may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cardiac Valvulotome. The growth and trends of Cardiac Valvulotome industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cardiac Valvulotome market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Expandable Cardiac Valvulotome
Over the Wire Cardiac Valvulotome

By Procedure Type

Valvulotomy
Mitral Valve Commissurotomy
Others (Tricuspid Valve Stenosis, etc.)

By End-user

Hospitals & Clinics
Cardiac Surgery Centers
Ambulatory Surgical Centers
Others (research Institutes, etc.)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cardiac Valvulotome market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cardiac Valvulotome market include LeMaitre, Invamed, LimFlow Inc., B. Braun, Teleflex Incorporated, StarFish Medical, Koven Technology Inc., BD, Symmetry Surgical Inc., Andramed GmbH, OxSyBio. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CARDIAC VALVULOTOME - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Procedure Type
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CARDIAC VALVULOTOME MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Expandable Cardiac Valvulotome Historic and Forecast Sales By Regions
5.4. Over the Wire Cardiac Valvulotome Historic and Forecast Sales By Regions

6. GLOBAL CARDIAC VALVULOTOME MARKET ANALYSIS BY PROCEDURE TYPE

6.1. Overview By Procedure Type
6.2. Historical and Forecast Data Analysis By Procedure Type
6.3. Valvulotomy Historic and Forecast Sales By Regions
6.4. Mitral Valve Commissurotomy Historic and Forecast Sales By Regions
6.5. Others (Tricuspid Valve Stenosis, etc.) Historic and Forecast Sales By Regions

7. GLOBAL CARDIAC VALVULOTOME MARKET ANALYSIS BY END-USER

7.1. Overview By End-user
7.2. Historical and Forecast Data Analysis By End-user
7.3. Hospitals & Clinics Historic and Forecast Sales By Regions
7.4. Cardiac Surgery Centers Historic and Forecast Sales By Regions
7.5. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
7.6. Others (research Institutes, etc.) Historic and Forecast Sales By Regions

8. GLOBAL CARDIAC VALVULOTOME MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CARDIAC VALVULOTOME COMPANIES

9.1. Cardiac Valvulotome Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF CARDIAC VALVULOTOME INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. LeMaitre
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Invamed
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. LimFlow Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. B. Braun
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Teleflex Incorporated
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. StarFish Medical
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Koven Technology Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. BD
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Symmetry Surgical Inc.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Andramed GmbH
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. OxSyBio
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments